Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation: The HCM-AF Score

Circ Arrhythm Electrophysiol. 2021 Jun;14(6):e009796. doi: 10.1161/CIRCEP.120.009796. Epub 2021 Jun 15.

Authors

Richard T Carrick¹, Martin S Maron¹, Arnon Adler^{2

3}, Benjamin Wessler¹, Sara Hoss^{2

3}, Raymond H Chan², Aadhavi Sridharan¹, Dou Huang¹, Craig Cooper¹, Jennifer Drummond¹, Harry Rakowski^{2

3}, Barry J Maron¹, Ethan J Rowin¹

Affiliations

¹ Hypertrophic Cardiomyopathy Institute, Division of Cardiology, Tufts Medical Center, Boston, MA (R.T.C., M.S.M., B.W., A.S., D.H., C.C., J.D., B.J.M., E.J.R.).
² Department of Cardiology, Peter Munk Cardiac Centre, Toronto General Hospital, Canada (A.A., S.H., R.H.C., H.R.).
³ Department of Medicine, University of Toronto, ON, Canada (A.A., S.H., H.R.).

PMID: 34129346
DOI: 10.1161/CIRCEP.120.009796

Abstract

[Figure: see text].

Keywords: atrial fibrillation; cardiomyopathy, hypertrophic; embolic stroke.

Publication types

Validation Study

MeSH terms

Atrial Fibrillation / epidemiology
Atrial Fibrillation / etiology*
Atrial Fibrillation / physiopathology
Cardiomyopathy, Hypertrophic / complications
Cardiomyopathy, Hypertrophic / diagnosis*
Echocardiography / methods*
Female
Follow-Up Studies
Heart Conduction System / physiopathology
Humans
Incidence
Magnetic Resonance Imaging, Cine / methods*
Male
Middle Aged
Ontario / epidemiology
Prognosis
Retrospective Studies
Risk Assessment / methods*
Risk Factors